Investors: ARK Invest, BlackRock, Eclipse, T. Rowe Price Investment Management, Baillie Gifford, Duquesne Family Office, Intuitive Ventures, EDBI, Gates Frontier, DC Global Ventures, DFJ Growth, Willett Advisors
Cellares, an integrated development and manufacturing organization for automated cell therapy production, received a $20 million investment from ARK Invest, bringing its Series D to $277 million total for scaling global smart factories.